{
    "2020-04-02": [
        [
            {
                "time": "2019-12-31",
                "original_text": "【面包财报】天坛生物：2019年归母净利润6.11亿元，同比增长19.95%",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "归母净利润",
                        "同比增长",
                        "2019年年报"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-31",
                "original_text": "天坛生物（600161）：业绩符合预期，即将迈入快速增长期【2019年年报点评|西南医药朱国广/杜向阳团队】",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩符合预期",
                        "快速增长期",
                        "西南医药",
                        "年报点评"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}